X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Cancer Medicine

期刊標題檢索 CANCER MED-US 最新評論: It looks like it hasn't been submitted for review. (2026-04-01)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Cancer Medicine]您好,您是該頁面的第 1073538 位訪客。

期刊簡介
期刊名稱Cancer Medicine Cancer Medicine
LetPub Score
6.4
50 ratings
Rate

Reputation
7.1

Influence
5.4

Speed
8.2

期刊簡稱CANCER MED-US
ISSN2045-7634
h-index34
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.001.2010.878
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q292 / 346
Category: Medicine
Subcategory: Oncology
Q2157 / 415
Category: Medicine
Subcategory: Cancer Research
Q3122 / 233

自引率 (2023-2024)3.40%自引率趨勢
掲載範囲
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations

Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.

Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.

Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.


Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634
在線稿件提交https://mc.manuscriptcentral.com/cancermedicine
開放訪問Yes
出版商John Wiley and Sons Ltd
主題領域ONCOLOGY
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數1046每年文章數趨勢
黃金OA百分比96.43%
OA Related Info
APC: Yes( USD4070; GBP2640; EUR3080; )
APC waiver:Check Notes
Other charges: No
Keywords: cancer biology、cancer medicine、cancer prevention、bioinformatics
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ2142/328
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2045-7634%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 19 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Cancer Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 1154.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 181.80
    LANCETH-index: 700

    CiteScore: 87.60
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 96.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 114.50
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 113.30
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 103.80
    MMWR Recommendations and ReportsH-index: 0

    CiteScore: 129.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 84.70
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 30.80
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY23304795
    Frontiers in Pharmacology6572331
    Oncology Letters1615638
    BIOMATERIALS1576843
    Oncogenesis1006999
    JOURNAL OF ETHNOPHARMACOLOGY723624
    Archives of Medical Science718727
    MEDICINE702930
    Frontiers in Oncology594347
    Frontiers in Immunology590384
  •  

    Cancer Medicine Cancer Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/53)
  [Cancer Medicine] 的評論撰寫評論
作者: SCI文章翻译润色发表


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-01 13:36:05 評論於
It looks like it hasn't been submitted for review.
(0) 讚! | SCI文章翻译润色发表

作者: woslinzili


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-03-30 11:46:35 評論於
How are you now?
(0) 讚! | woslinzili

作者: woslinzili


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-03-25 11:31:59 評論於
Is there any news?
(0) 讚! | woslinzili

作者: woslinzili


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-03-25 08:30:44 評論於
It has been over ten days since I submitted my manuscript, and it is currently showing as "under review." What is the situation? Has it been sent out for external review?
(0) 讚! | woslinzili

作者: Jin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-03-23 14:05:57 評論於
Any news?
(0) 讚! | Jin

作者: Jin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-03-23 14:05:24 評論於
Has this status been submitted for review or not?
(0) 讚! | Jin

作者: sicpgld


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-01-22 09:18:46 評論於
Is there a situation? Is it an external audit?
(0) 讚! | sicpgld

作者: Wang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-31 22:22:31 評論於
May I ask about the submission made last month? Scholar One shows UR, ADM: Editorial Office, Cancer Medicine. Was this sent for external review or are you still looking for reviewers?
(0) 讚! | Wang

作者: HZY


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-06 10:58:18 評論於
Any news???
(0) 讚! | HZY

作者: HZY


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-24 15:57:33 評論於
Is there a result, what does this mean?
(0) 讚! | HZY

作者: 徐同学


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-21 14:46:55 評論於
Could you please tell me if my submission being under review the day after I submitted it means it has been sent for external review?
(0) 讚! | 徐同学

作者: longzg


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2025-03-09 10:15:47 評論於
Received an email in the morning on March 9th.
(0) 讚! | longzg

作者: longzg


領域: 医学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-08 09:59:28 評論於
3.7 View status pending decision.
(0) 讚! | longzg

作者: longzg


領域: 医学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-06 20:46:26 評論於
3.6 Viewing status Pending Recommendation.
(0) 讚! | longzg

作者: 可洛卡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-02-27 17:09:11 評論於
How long did you wait roughly behind? I have been waiting for a month after paying the fee and still haven't received the proof.
(0) 讚! | 可洛卡

作者: 可洛卡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-02-27 17:07:28 評論於
Hello, may I ask how long does it take to receive proof after payment? It has been a month and it is still in production.
(0) 讚! | 可洛卡

作者: longzg


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2025-02-18 19:48:05 評論於
The newly established Area 2 is keeping up with the tumor Area 3. When submitting manuscripts, you can submit them through the pre-review platform for faster external review.
On 2.8, submitted on the official pre-review platform of Wiley, said it can be sent for external review.
On 1.10, submitted on the Wiley official website, under initial checking the same day.
On 1.15, under review.
On 2.7, under decision.
On 2.11, major revisions were made, and the comments from the two reviewers were pertinent and crucial, and the suggested revisions were also very detailed.
On 2.17, revised, under initial checking the same day.
On 2.18, pending recommendation, under review the same evening.
It is estimated that it will take another month.
(0) 讚! | longzg

作者: 可洛卡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-15 08:53:16 評論於
On November 14th, I received the revision email and the status changed to major revision.
(0) 讚! | 可洛卡

作者: 可洛卡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-14 13:57:04 評論於
11.14 pending decision I don't know if it has been sent for external review or not, it's been under review for 2 weeks. If it hasn't been sent for review, then it's definitely not going to work out.
(0) 讚! | 可洛卡

作者: 可洛卡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-31 13:24:17 評論於
10.31 under review.
(0) 讚! | 可洛卡

作者: 可洛卡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-25 10:23:57 評論於
10.23 Reminder to supplement unclear images and re-upload. undergoing initial checking on the same day.
10.25 Changed to pending editor assignment.
(0) 讚! | 可洛卡

作者: 可洛卡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 13:20:45 評論於
Record the progress:
10.22 Submitted for review, undergoing initial checking.
(0) 讚! | 可洛卡

作者: 五毒倩利


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 22:59:18 評論於
Hello, may I ask if I received the email "accepted" yesterday, will I receive the payment email for the communication immediately?
(0) 讚! | 五毒倩利

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-19 15:19:13 評論於
Review speed: 3.0 | Submission success rate: 50.0 
Research focus: Colorectal cancer
Experience sharing: Submitted on July 25th, still not finished the first review. Have reminded several times, still no response. It's really frustrating.
(0) 讚! | Adelaide Lawson

作者: 吴雯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-15 21:40:33 評論於
Submitted on October 4, 2024, the format was incorrect and it was sent back. Submitted again on October 6, it showed as undergoing initial checking, then changed to pending editor assignment. It remained in this status until October 15. Is this timeframe normal?
(0) 讚! | 吴雯

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/53)

開始撰寫 [Cancer Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*